Alignment Pillar

AI Alignment Platform

Bridge the gap between scientific knowledge and AI models through expert validation.

Preview — metrics are deterministic until sign-in lands

Preview surface. Claim text, trial references, and domain tags are from the live corpus. Accuracy, confidence, expert profiles, and vote counts shown on each card are deterministic previews derived from each claim id — they will be replaced by real validation aggregates once expert sign-in lands.

Expert Contributors

+8.3%

892

Validated Responses

+16.7%

45.2K

Alignment Score

+2.1%

94.3%

Verified Factoids

+3.8%

12,453

Real-time RLHF

Provide expert feedback to improve model responses in real time.

Response Evaluation

Rate model outputs

Start Rating

Performance Metrics

Track improvements

View Stats

Learn more about RLHF

Scientific Factoids

Curate and validate scientific knowledge for AI training.

Validate Facts

Review and verify

Start Review

Expert Network

Connect & collaborate

Join Network

Browse database → (54 of 116 verified factoids)

Latest Scientific Factoids

Expert-validated claims from the live corpus.

View all →

Vascular Neurology

Impact 60

Human

Pending

The MONALEESA-2 trial's stated primary conclusion — Adding ribociclib to letrozole improves progression-free survival in HR+/HER2− advanced breast cancer. — replicates in independent cohorts.

oncology

78%

Accuracy

95%

Confidence

77%

Established

Posted 19/03/26 · Updated 21/04/26

Clinical Neurophysiology

Impact 60

Human

Pending

Pembrolizumab (10 mg/kg every 2 weeks) improves 12-month overall survival to 74.1% versus 58.2% for ipilimumab (HR 0.63, P=0.0005) in patients with advanced melanoma.

oncology

pharmacology

83%

Accuracy

67%

Confidence

60%

Established

Posted 22/01/26 · Updated 21/04/26

Neuroradiology

Impact 60

Verified

Recent follow-up analyses of CLARITY-AD (lecanemab) are confirming the original effect size in real-world data.

neurology

91%

Accuracy

65%

Confidence

74%

Established

Posted 20/04/26 · Updated 21/04/26

Cardiology

Impact 61

Human

Pending

Recent follow-up analyses of EARLYSTIM are confirming the original effect size in real-world data.

neurology

73%

Accuracy

82%

Confidence

84%

Established

Posted 28/03/26 · Updated 21/04/26

Browse all factoids